Juli Miller | Senior Director, IR |
Adrian Rawcliffe | CEO |
Elliot Norry | Senior VP and Chief Medical Officer |
Helen Tayton-Martin | Co-Founder and Chief Business Officer |
Tony Butler | ROTH Capital |
David Ruch | SVB Leerink |
Gabriel Fung | Mizuho Securities |
Ladies and gentlemen, thank you for standing by, and welcome to Adaptimmune's Third Quarter 2020 Financial Results and Business Update. At this time, all participants are in a listen-only mode. [Operator Instructions] Please be advised that today's conference may be recorded. [Operator Instructions] I would now like to hand the conference over to your host, Adaptimmune's Investor Relations, Juli Miller. Madam, please go ahead.